Study finds link between cannabinoid receptors, PTSD

05/14/2013 | MedicalDaily.com

A study using PET imaging found patients with PTSD had more cannabinoid type 1 receptors in brain areas associated with anxiety and fear compared with those who did not have the condition. The study, published in Molecular Psychiatry, also found that patients with PTSD had lower levels of the neurotransmitter anandamide, which causes greater numbers of CB1 receptors. The findings may help improve diagnosis and treatment of people with the condition.

View Full Article in:

MedicalDaily.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC